ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense
- 1 October 2004
- journal article
- review article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 8, 31-44
- https://doi.org/10.1016/j.ijid.2004.09.002
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A novel, cell culture-derived smallpox vaccine in vaccinia-naïve adultsVaccine, 2005
- Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination11The views expressed in this study are those of the authors and do not reflect the official policy or position of the U.S. government.Journal of the American College of Cardiology, 2004
- Clinical Responses to Undiluted and Diluted Smallpox VaccineNew England Journal of Medicine, 2002
- Dose-Related Effects of Smallpox VaccineNew England Journal of Medicine, 2002
- Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein IVaccine, 1996
- Isolation and characterization of attenuated mutants of vaccinia virusVirology, 1987
- Biogenesis of poxviruses: Mirror-image deletions in vaccinia virus DNACell, 1979
- Vaccinia virus variants as presumable cause of vaccinial complicationsArchiv für die gesamte Virusforschung, 1975
- Qualitätsunterschiede von Vacciniaviren bei normalem und gestörtem Impfverlauf (mit neuralen Komplikationen)Deutsche Medizinische Wochenschrift (1946), 1975
- Complications of Smallpox Vaccination, 1968: Results of Ten Statewide SurveysThe Journal of Infectious Diseases, 1970